1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. OMEGA THERAPEUTICS INC
Omega Therapeutics Inc XNAS: OMGAQ

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Omega Therapeutics Inc is on 04 Jul 2025 for the purpose of Omega Therapeutics Inc First Quarter Earnings Results for 2025 See details


Insider Trading disclosures for Omega Therapeutics Inc

The latest disclosure was made by Mehrotra Ravi in Omega Therapeutics Inc where a trade of 50,000 Stock Option (Right to Buy) done was reported to US exchanges on Dec. 3, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Mehrotra Ravi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Dec 2024 50,000 50,000 - - Stock Option (Right to Buy)
Jennifer Ann Nelson Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Nov 2024 110,000 110,000 - - Stock Option (Right to Buy)
Kaan Certel Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Nov 2024 340,000 340,000 - - Stock Option (Right to Buy)
Robert L. Rosiello Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Oct 2024 50,000 50,000 - - Stock Option (Right to Buy)
John D. Mendlein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 25,000 25,000 - - Stock Option (Right to Buy)
Christian Stanton Schade Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 25,000 25,000 - - Stock Option (Right to Buy)
Mary T. Szela Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 25,000 25,000 - - Stock Option (Right to Buy)
Richard N. Kender Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 50,000 50,000 - - Stock Option (Right to Buy)
Richard A. Young Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 25,000 25,000 - - Stock Option (Right to Buy)
Rainer J. Boehm Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 25,000 25,000 - - Stock Option (Right to Buy)
Elliott M. Levy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 25,000 25,000 - - Stock Option (Right to Buy)
Michelle C. Werner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 25,000 25,000 - - Stock Option (Right to Buy)
Kaan Certel Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2024 220,000 220,000 - - Stock Option (Right to Buy)
Thomas McCauley Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 75,000 75,000 - - Stock Option (Right to Buy)
Thomas McCauley Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 125,000 125,000 - - Stock Option (Right to Buy)
Reed Joshua Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 110,000 110,000 - - Stock Option (Right to Buy)
Schade Stanton Christian Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 512,848 512,848 - - Stock Option (Right to Buy)
Karande Mahesh Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 314,326 314,326 - - Stock Option (Right to Buy)
Zeng Ling See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 125,000 125,000 - - Stock Option (Right to Buy)
Mahesh Karande Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 209,551 209,551 - - Stock Option (Right to Buy)
Yan Moore Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2024 110,000 110,000 - - Stock Option (Right to Buy)
Michelle C. Werner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Aug 2023 36,713 36,713 - - Stock Option (Right to Buy)
Schade Christian Stanton Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jul 2023 36,713 36,713 - - Stock Option (Right to Buy)
Christian Stanton Schade Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jul 2023 36,713 36,713 - - Stock Option (Right to Buy)
Luke M. Beshar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 18,118 18,118 - - Stock Option (Right to Buy)
Mary T. Szela Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 18,118 18,118 - - Stock Option (Right to Buy)
Noubar B. Afeyan Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 18,118 18,118 - - Stock Option (Right to Buy)
John D. Mendlein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 18,118 18,118 - - Stock Option (Right to Buy)
Richard A. Young Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 18,118 18,118 - - Stock Option (Right to Buy)
Rainer J. Boehm Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 18,118 18,118 - - Stock Option (Right to Buy)
Elliott M. Levy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 18,118 18,118 - - Stock Option (Right to Buy)
Richard A. Young Director Sale of securities on an exchange or to another person at price $ 8.00 per share. 02 Jun 2023 5,000 739,118 - 8 40,000 Common Stock
Richard A. Young Director Sale of securities on an exchange or to another person at price $ 8.00 per share. 01 May 2023 5,000 744,118 - 8 40,000 Common Stock
Richard A. Young Director Sale of securities on an exchange or to another person at price $ 8.00 per share. 06 Apr 2023 5,000 749,118 - 8 40,000 Common Stock
Richard A. Young Director Sale of securities on an exchange or to another person at price $ 8.00 per share. 17 Mar 2023 10,000 754,118 - 8 80,000 Common Stock
Yan Moore Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2023 55,000 55,000 - - Option (Right to Buy)
Ling Zeng See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2023 55,000 55,000 - - Option (Right to Buy)
Mahesh Karande Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2023 170,000 170,000 - - Option (Right to Buy)
Kevin McManus Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2023 55,000 55,000 - - Option (Right to Buy)
Thomas McCauley Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2023 55,000 55,000 - - Option (Right to Buy)
Joshua Reed Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2023 55,000 55,000 - - Option (Right to Buy)
Richard A. Young Director Sale of securities on an exchange or to another person at price $ 8.00 per share. 10 Jan 2023 20,000 764,118 - 8 160,000 Common Stock
Richard A. Young Director Sale of securities on an exchange or to another person at price $ 8.00 per share. 14 Sep 2022 10,000 784,118 - 8 80,000 Common Stock
Rainer Boehm Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Aug 2022 36,713 36,713 - - Option (Right to Buy)
Richard A. Young Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2022 18,118 18,118 - - Option (Right to Buy)
Elliott M. Levy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2022 18,118 18,118 - - Option (Right to Buy)
John D. Mendlein Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2022 18,118 18,118 - - Option (Right to Buy)
Noubar B. Afeyan Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2022 18,118 18,118 - - Option (Right to Buy)
Mary T. Szela Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2022 18,118 18,118 - - Option (Right to Buy)
Luke M. Beshar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2022 18,118 18,118 - - Option (Right to Buy)
Joshua Reed Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2022 320,000 320,000 - - Option (Right to Buy)
Kevin McManus Chief Human Resources Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2022 125,000 125,000 - - Option (Right to Buy)
Ling Zeng See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2022 270,000 270,000 - - Option (Right to Buy)
Thomas McCauley Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2022 110,000 110,000 - - Option (Right to Buy)
Mahesh Karande Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2022 340,000 340,000 - - Option (Right to Buy)
Roger Sawhney Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Mar 2022 60,000 60,000 - - Option (Right to Buy)
Mahesh Karande Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.53 per share. 01 Feb 2022 11,300 117,711 - 0.5 5,989 Common Stock
Mahesh Karande Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Feb 2022 11,300 884,071 - - Option (Right to Buy)
Yan Moore Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2022 477,715 477,715 - - Option (Right to Buy)
Roger Sawhney Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 17.00 per share. 03 Aug 2021 2,941 2,941 - 17 49,997 Common Stock
Noubar B. Afeyan Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2021 19,852 19,852 - - Stock Option (Right to Buy)
Luke M. Beshar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2021 52,941 52,941 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters